4 ms·

This was overturned in court.[1][2] [1]http://bcaction.org/2013/06/13/breast-cancer-action-wins-scotus-overturns-human-gene-patents/?printerfriendly http://bca

• aheilbut 13y ago
  Sort of, but there are still numerous patents on BRCA testing that were not part of the SCOTUS ruling, which Myriad is continuing to try to enforce: http://www.businessweek.com/news/2013-07-09/myriad-genetics-sues-ambry-to-halt-rival-breast-cancer-test-1 http://www.businessweek.com/news/2013-07-09/myriad-genetics-... There really need to be some kind of novel legal structures to cover this kind of testing. There do need to be incentives (temporary monopolies) for companies to discover, develop and validate tests, because it is expensive and takes a long time. On the other hand, there should be incentives to disseminate useful tests as quickly as possible at a fair price, and there shouldn't be undue restrictions on research. But it can't be a free-for-all either.